Trademark: OXYGENE 2075095
Word
OXYGENE
ID
2075095
Trademark Type
WORD
Status
Protected: Registered/protected
Application Date
15 January 2020
Registration Date
15 January 2020
Renewal Date
15 January 2030
Owner(s)
Service
Spruson & Ferguson
Goods and Services:
Class 40:
Supply of production units for biological molecules, particularly viral vectors and monoclonal antibodies, in the pharmaceutical and biopharmaceutical field; contract manufacturing of biological molecules, particularly viral vectors and monoclonal antibodies, in the pharmaceutical and biopharmaceutical field; production of biological molecules, particularly viral vectors and monoclonal antibodies, in the pharmaceutical and biopharmaceutical field.
Supply of production units for biological molecules, particularly viral vectors and monoclonal antibodies, in the pharmaceutical and biopharmaceutical field; contract manufacturing of biological molecules, particularly viral vectors and monoclonal antibodies, in the pharmaceutical and biopharmaceutical field; production of biological molecules, particularly viral vectors and monoclonal antibodies, in the pharmaceutical and biopharmaceutical field.
Class 42:
Study of production factories and buildings; inspection of production factories and buildings (expertise); technical studies; quality control of production units in the pharmaceutical and biopharmaceutical field with a view to certification; research and development of new products for third parties; technological services regarding manufacture of biological molecules, particularly viral vectors and monoclonal antibodies, in the pharmaceutical and biopharmaceutical field.
Study of production factories and buildings; inspection of production factories and buildings (expertise); technical studies; quality control of production units in the pharmaceutical and biopharmaceutical field with a view to certification; research and development of new products for third parties; technological services regarding manufacture of biological molecules, particularly viral vectors and monoclonal antibodies, in the pharmaceutical and biopharmaceutical field.